Perkins Adelene Q

Insider CIK 1375124 · BRKR Director · INFI See Remarks, Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
BRKR BRUKER CORP	A Award	2026-02-15	2026-02-18	4,520	—	$0	29,144	SEC↗
BRKR BRUKER CORP	A Award	2025-02-15	2025-02-19	3,298	—	$0	24,624	SEC↗
BRKR BRUKER CORP	A Award	2024-01-05	2024-01-09	2,377	—	$0	21,326	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2023-09-12	2023-09-12	410,196	$0.07	$28.7K	1,175,291	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise deriv	2023-09-09	2023-09-12	768,133	—	$0	0	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise	2023-09-09	2023-09-12	768,133	—	$0	1,585,487	SEC↗
BRKR BRUKER CORP	A Award	2023-01-05	2023-01-09	1,970	—	$0	18,949	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2022-01-11	2022-01-12	576,100	—	$0	576,100	SEC↗
BRKR BRUKER CORP	A Award	2022-01-05	2022-01-06	1,841	—	$0	16,979	SEC↗
BRKR BRUKER CORP	A Award	2021-01-05	2021-01-07	2,302	—	$0	15,138	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2020-12-22	2020-12-23	485,000	—	$0	485,000	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2020-01-10	2020-01-13	606,250	—	$0	606,250	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award	2020-01-10	2020-01-13	155,134	—	$0	793,190	SEC↗
BRKR BRUKER CORP	A Award	2020-01-06	2020-01-07	2,472	—	$0	12,836	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2019-06-13	2019-06-14	242,000	—	$0	242,000	SEC↗
BRKR BRUKER CORP	A Award	2019-01-07	2019-01-10	4,134	—	$0	10,364	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2019-01-04	2019-01-07	243,000	—	$0	243,000	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2018-10-01	2018-10-02	5,000	$2.82	$14.1K	609,561	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2018-03-05	2018-03-07	5,000	$2.78	$13.9K	607,252	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2018-01-08	2018-01-09	500,000	—	$0	500,000	SEC↗
BRKR BRUKER CORP	A Award	2018-01-05	2018-01-09	3,474	—	$0	6,230	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2018-01-02	2018-01-04	180,000	—	$0	180,000	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award	2018-01-02	2018-01-04	69,924	—	$0	612,252	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award	2017-07-21	2017-07-24	85,800	—	$0	535,020	SEC↗
BRKR BRUKER CORP	A Award	2017-05-31	2017-06-01	2,756	—	$0	2,756	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2017-01-06	2017-01-09	1,000,000	—	$0	1,000,000	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award	2016-10-31	2017-04-14	85,800	—	$0	449,220	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award	2016-10-31	2016-11-02	85,800	—	$0	447,411	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2016-01-06	2016-01-08	185,000	—	$0	185,000	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2015-06-25	2015-06-26	5,000	$10.93	$54.6K	359,432	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2015-05-27	2015-05-28	10,000	$12.81	$128.1K	364,432	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2015-05-14	2015-05-15	10,000	$12.18	$121.8K	374,432	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2015-03-16	2015-03-17	20,000	$16.00	$320.0K	384,432	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2015-03-05	2015-03-09	25,000	$16.50	$412.5K	404,432	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2015-01-29	2015-02-02	20,000	$14.83	$296.6K	427,535	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2015-01-29	2015-03-09	20,000	$14.83	$296.6K	429,432	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2015-01-14	2015-01-16	250,000	—	$0	250,000	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2014-01-10	2014-01-14	85,500	—	$0	85,500	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2013-09-13	2013-09-13	13,076	$20.50	$268.1K	447,535	SEC↗
INFI INFINITY PHARMACEUTICALS,	S Sale	2013-09-12	2013-09-13	31,924	$20.81	$664.3K	460,611	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2013-01-04	2013-01-08	153,835	—	$0	153,835	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise deriv	2012-12-07	2012-12-10	331	—	$0	0	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise deriv	2012-12-07	2012-12-10	13,927	—	$0	0	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise deriv	2012-12-07	2012-12-10	23,070	—	$0	340,930	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise deriv	2012-12-07	2012-12-10	76,930	—	$0	83,620	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise deriv	2012-12-07	2012-12-10	10,204	—	$0	0	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise deriv	2012-12-07	2012-12-10	29,432	—	$0	0	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise deriv	2012-12-07	2012-12-10	22,103	—	$0	0	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise	2012-12-07	2012-12-10	29,432	$13.59	$400.0K	368,404	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise	2012-12-07	2012-12-10	331	$3.48	$1.2K	338,972	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise	2012-12-07	2012-12-10	22,103	$3.48	$76.9K	338,641	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise	2012-12-07	2012-12-10	13,927	$7.18	$100.0K	392,535	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise	2012-12-07	2012-12-10	23,070	$6.25	$144.2K	415,605	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise	2012-12-07	2012-12-10	76,930	$5.94	$457.0K	492,535	SEC↗
INFI INFINITY PHARMACEUTICALS,	M Exercise	2012-12-07	2012-12-10	10,204	$9.80	$100.0K	378,608	SEC↗
INFI INFINITY PHARMACEUTICALS,	A Award deriv	2012-01-06	2012-01-09	191,750	—	$0	191,750	SEC↗